Giuseppe Toffoli
Basic info is private.
Interests
Nanomedicine; Pre-Clinical and Clinical Pharmacology; Molecular and Biochemical Mechanisms; Genomics of Anti-Cancer Drugs and technology transfer
Latest Publications
- Open Access Research articleDPYD Gene Activity Score Predicts Dose-Limiting Toxicity in Fluoropyrimidine-Treated Colorectal Cancer PatientsDalle Fratte Chiara, Polesel Jerry, Roncato Rossana, De Mattia Elena, ... Cecchin ErikaJ. Mol. Clin. Med. 2018, 1(3), 143–150; https://doi.org/10.31083/j.jmcm.2018.03.00326Downloads2Citations148Views
- Open Access CommentaryDoes PD1/PDL1 Immunotherapy Require Patient Tumor Subgroup Pre-Analysis in the Era of Precision Medicine?Lucia Scarabel, Giuseppe ToffoliJ. Mol. Clin. Med. 2018, 1(1), 51–54; https://doi.org/10.31083/j.jmcm.2018.01.00715Downloads40Views